Ledger.Open graph →
SEC Form D · Amendment · filed March 10, 2011

LIMERICK BIOPHARMA INC

Offering
$6.9M
Sold
$6.9M
Exemption
—
Industry
Pharmaceuticals
Location
SO. SAN FRANCISCO, CA
Type
—

People & firms on this filing (14)

Chad Waite · South San Francisco, CADirectorWendye Robbins · South San Francisco, CAExec · DirectorCorey Goodman · South San Francisco, CADirectorSteve Dow · South San Francisco, CADirectorVing Lee · South San Francisco, CAExecKristina Burow · South San Francisco, CADirectorAsha Rajagopal · South San Francisco, CAExecJack Shields · Campbell, CAExec · DirectorBrian Owen · Campbell, CAExecPaul Hanlon · Alexandria, VAExecPaul Spurgeon · Alexandria, VADirectorRobert C. Clutterbuck · Cleveland, OHDirectorRyan R. Crane · Cleveland, OHDirectorLarry R. Gury · Orangevale, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗